Search Results - Hanbing Lyu
- Showing 1 - 1 results of 1
-
1
HDAC5, an early osimertinib-responsive gene, is a novel therapeutic target for the drug resistance in EGFR-mutant lung adenocarcinoma cells by Hanbing Lyu, Akihiko Ishimura, Ryusuke Suzuki, Khurelsukh Buyanbat, Gerelsuren Batbayar, Makiko Meguro-Horike, Shin-ichi Horike, Seiji Yano, Takeshi Suzuki
Published in Biochemistry and Biophysics Reports (2025-06-01)Get full text
Article